Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 4,100 shares, a decrease of 33.9% from the November 30th total of 6,200 shares. Based on an average trading volume of 34,900 shares, the days-to-cover ratio is currently 0.1 days.

Bavarian Nordic A/S Price Performance

Shares of BVNRY traded up $0.26 during trading hours on Friday, hitting $8.98. 8,435 shares of the company were exchanged, compared to its average volume of 32,110. The firm has a fifty day simple moving average of $9.43 and a 200-day simple moving average of $9.99. The company has a market capitalization of $2.12 billion, a PE ratio of 13.01 and a beta of 1.65. Bavarian Nordic A/S has a one year low of $6.86 and a one year high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.